Triple Negative Breast Cancer (TNBC) is a unique and aggressive subtype of Breast Cancer that requires timely diagnosis and specialized care. Unlike other types of breast cancer, TNBC does not have estrogen receptors, progesterone receptors, or HER2 protein expression, making it more challenging to treat with standard hormonal therapies. Under the expert guidance of Best Cancer Doctor in Bommanahalli patients can access advanced care and personalized treatment approaches.

What is Triple Negative Breast Cancer?
Triple Negative Breast Cancer accounts for about 10–15% of all breast cancer cases. It is called “triple negative” because it tests negative for three common receptors known to fuel most breast cancers:
- Estrogen receptors (ER)
- Progesterone receptors (PR)
- HER2 protein
Due to the absence of these receptors, TNBC does not respond to hormone therapy or HER2-targeted treatments, making chemotherapy the primary treatment option.
Causes and Risk Factors
While the exact cause of TNBC is not fully understood, several risk factors are associated with it:
- Genetic mutations (especially BRCA1)
- Younger age at diagnosis
- Family history of breast cancer
- Obesity and lifestyle factors
Early screening and awareness are crucial, especially for high-risk individuals.
Symptoms to Watch For
Symptoms of TNBC are similar to other breast cancers and may include:
- A lump or thickening in the breast
- Changes in breast size or shape
- Skin dimpling or redness
- Nipple discharge
- Pain in the breast or nipple area
If you notice any of these symptoms, consult a specialist immediately for evaluation.
Diagnosis
Diagnosis typically involves:
- Clinical breast examination
- Mammography
- Ultrasound or MRI
- Biopsy to confirm TNBC subtype
Accurate diagnosis helps in determining the best treatment plan.
Treatment Options
Since TNBC lacks hormone receptors, treatment focuses on:
1. Chemotherapy
The most effective and commonly used treatment.
2. Surgery
- Lumpectomy or mastectomy depending on tumor size and spread
3. Radiation Therapy
Used after surgery to eliminate remaining cancer cells
4. Immunotherapy & Targeted Therapy
Emerging treatments that show promise in improving outcomes
Prognosis and Survival
TNBC tends to grow and spread faster than other breast cancers, but early detection significantly improves outcomes. With advances in oncology, survival rates are improving through personalized treatment strategies.
Importance of Early Detection
Regular screening, especially for women with risk factors, can make a life-saving difference. Early-stage TNBC is more responsive to treatment and has better outcomes.
Why Choose Expert Care?
Managing TNBC requires a multidisciplinary approach involving oncologists, radiologists, and surgeons. Choosing an experienced specialist ensures accurate diagnosis, advanced treatment, and compassionate care throughout the journey.
FAQ – Triple Negative Breast Cancer
1. Is Triple Negative Breast Cancer curable?
Yes, especially when detected early. Treatment success depends on the stage and response to therapy.
2. Why is TNBC considered aggressive?
It grows and spreads faster and lacks targeted treatment options compared to other breast cancers.
3. Can TNBC come back after treatment?
There is a higher risk of recurrence within the first few years, but regular follow-ups help in early detection.
4. Who is at higher risk for TNBC?
Younger women, those with BRCA1 mutations, and individuals with a family history of breast cancer.
5. Are there new treatments available?
Yes, immunotherapy and targeted therapies are emerging as promising options.
Contact Details
Ikshana Multispeciality & Diagnostics
Marvi Arcade, 982, 5th Main Rd, 1st Block, Kodichikknahalli,
DUO Layout, Bommanahalli,
Bengaluru, Karnataka 560076
📞 Phone: +91 80500 69992
🌐 Website: www.ikshanamultispecialityanddiagnosticcentre.com
Early diagnosis and expert care can make all the difference in fighting Triple Negative Breast Cancer. If you or your loved ones need guidance, consult the Best Cancer Doctor in Bommanahalli for comprehensive and compassionate cancer care.